Ionis Pharmaceuticals, Inc. Increase (Decrease) in Income Taxes Receivable
Ionis Pharmaceuticals, Inc. (IONS) reported Increase (Decrease) in Income Taxes Receivable of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-24.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInIncomeTaxesReceivable · last filed 2021-02-24
- Ionis Pharmaceuticals, Inc. increase (decrease) in income taxes receivable for fiscal 2020 was $0.00.
- Ionis Pharmaceuticals, Inc. increase (decrease) in income taxes receivable for fiscal 2019 was -$8.42M, a 3874.89% decline from fiscal 2018.
- Ionis Pharmaceuticals, Inc. increase (decrease) in income taxes receivable for fiscal 2018 was $223.00K, a 97.55% decline from fiscal 2017.
- Ionis Pharmaceuticals, Inc. increase (decrease) in income taxes receivable for fiscal 2017 was $9.11M.
| Period end | Increase (Decrease) in Income Taxes Receivable 12 month |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-02-24 |
| 2019-12-31 | -$8.42M 10-K · filed 2021-02-24 |
| 2018-12-31 | $223.00K 10-K · filed 2021-02-24 |
| 2017-12-31 | $9.11M 10-K · filed 2020-03-02 |
| 2016-12-31 | $0.00 10-K · filed 2019-03-01 |
| 2015-12-31 | $0.00 10-K · filed 2018-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |